Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 61 5
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/09/2021 15 8
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/24/2021 7 2
Teicoplanin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021 2 1
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/22/2021 8 0
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/06/2021 8 0
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 10 1
Itolizumab Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/25/2020 3 0
Acarbose Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020 3 0
Ursolic acid Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020 2 0